Rezamid Acne Lotion (11086-022)

Manufacturer: Summers Laboratories Inc
Effective date: 2026-10-08
Label type: HUMAN OTC DRUG LABEL
Version: 10
Source: daily-update
Hydrated at: 2026-10-13 04:04:17

Label at a glance#

ProductREZAMID

Active ingredientSULFUR, RESORCINOL

Label structure10 sections

Dosage and administration

shake very well before using clean the skin thoroughly before applying this product cover the entire affected area with a thin layer one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other...

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

SULFUR 5%

RESORCINOL 2%

PURPOSE

OTC - PURPOSE SECTION

ACNE TREATMENT LOTION

USE

INDICATIONS & USAGE SECTION

DRIES UP ACNE PIMPLES, HELPS PREVENT NEW PIMPLES

WARNINGS

WARNINGS SECTION

FOR EXTERNAL USE ONLY

OTC - DO NOT USE SECTION

DO NOT USE

ON BROKEN SKIN
ON LARGE AREAS OF THE BODY

OTC - WHEN USING SECTION

WHEN USING THIS PRODUCT

APPLY TO AFFECTED AREAS ONLY
DO NOT GET INTO EYES
skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time

OTC - STOP USE SECTION

STOP USE AND ASK A DOCTOR IF

IF SKIN IRRITATION OCCURS OR GETS WORSE

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

shake very well before using
clean the skin thoroughly before applying this product
cover the entire affected area with a thin layer one to three times daily
because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
if bothersome dryness or peeling occurs, reduce application to once a day or every other day

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

water, SD-40 alcohol 28%, zinc oxide, talc, titanium dioxide, propylene glycol, attapulgite, lauramide DEA, iron oxides, sodium bisulfite, PEG-8 laurate, parachlorometaxylenol, hydroxyethylcellulose, sodium chloride, sodium polynapthalene sulfonate, EDTA, methyl paraben, xanthan gum, butylparaben, fragrance, simethicone.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Rezamid_Unit Carton

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
777d68c6-a5ab-e06c-d314-677b0b9af0c8	Product name	2	20240508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
11086-022-01	2025-01-30	C162847	48780-1	f386c649-99aa-0266-e053-dadaa90a7c1a	SUMMERS LABS (as PLD) - REZAMID (11086-022)
11086-022-01	2025-01-30	C162847	48780-1	f386c649-99aa-0266-e053-dadaa90a7c1a	Rezamid Acne Lotion (11086-022)
11086-022-01	2023-08-05	C162847	48780-1	f386c649-99aa-0266-e053-dadaa90a7c1a	SUMMERS LABS (as PLD) - REZAMID (11086-022)
11086-022-01	2023-08-05	C162847	48780-1	f386c649-99aa-0266-e053-dadaa90a7c1a	Rezamid Acne Lotion (11086-022)
11086-022-01	2023-01-30	C162847	48780-1	f386c649-99aa-0266-e053-dadaa90a7c1a	SUMMERS LABS (as PLD) - REZAMID (11086-022)
11086-022-01	2023-01-30	C162847	48780-1	f386c649-99aa-0266-e053-dadaa90a7c1a	Rezamid Acne Lotion (11086-022)

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
11086-022-01	GM - Gram	11086-022	c2e65bae-af72-4a4a-a43e-de702c661e4a	1	2013-12-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
RESORCINOL	ACTIVE INGREDIENT	YUL4LO94HK	3
SULFUR	ACTIVE INGREDIENT	70FD1KFU70	3
RESORCINOL	ACTIVE MOIETY	YUL4LO94HK	3
SULFUR	ACTIVE MOIETY	70FD1KFU70	3
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	3
ATTAPULGITE	INACTIVE INGREDIENT	U6V729APAM	3
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	3
CHLOROXYLENOL	INACTIVE INGREDIENT	0F32U78V2Q	3
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	3
EDETIC ACID	INACTIVE INGREDIENT	9G34HU7RV0	3
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	3
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)	INACTIVE INGREDIENT	8136Y38GY5	3
LAURIC DIETHANOLAMIDE	INACTIVE INGREDIENT	I29I2VHG38	3
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	3
PEG-8 LAURATE	INACTIVE INGREDIENT	762O8IWA10	3
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	3
SILICON	INACTIVE INGREDIENT	Z4152N8IUI	3
SODIUM BISULFITE	INACTIVE INGREDIENT	TZX5469Z6I	3
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	3
SODIUM NAPHTHALENESULFONATE	INACTIVE INGREDIENT	D3F8YRX7TP	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	3
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	3
ZINC OXIDE	INACTIVE INGREDIENT	SOI2LOH54Z	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

REZAMID
SULFUR AND RESORCINOL
SULFUR
RESORCINOL
WATER
ALCOHOL
ZINC OXIDE
TALC
TITANIUM DIOXIDE
PROPYLENE GLYCOL
ATTAPULGITE
LAURIC DIETHANOLAMIDE
FERRIC OXIDE RED
SODIUM BISULFITE
PEG-8 LAURATE
CHLOROXYLENOL
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)
SODIUM CHLORIDE
SODIUM NAPHTHALENESULFONATE
EDETIC ACID
METHYLPARABEN
XANTHAN GUM
BUTYLPARABEN
DIMETHICONE
SILICON

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
11086-022	11086-022-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SULFUR	70FD1KFU70	ACTIB
RESORCINOL	YUL4LO94HK	ACTIB
WATER	059QF0KO0R	IACT
ALCOHOL	3K9958V90M	IACT
ZINC OXIDE	SOI2LOH54Z	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
ATTAPULGITE	U6V729APAM	IACT
LAURIC DIETHANOLAMIDE	I29I2VHG38	IACT
FERRIC OXIDE RED	1K09F3G675	IACT
SODIUM BISULFITE	TZX5469Z6I	IACT
PEG-8 LAURATE	762O8IWA10	IACT
CHLOROXYLENOL	0F32U78V2Q	IACT
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)	8136Y38GY5	IACT
SODIUM CHLORIDE	451W47IQ8X	IACT
SODIUM NAPHTHALENESULFONATE	D3F8YRX7TP	IACT
EDETIC ACID	9G34HU7RV0	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
XANTHAN GUM	TTV12P4NEE	IACT
BUTYLPARABEN	3QPI1U3FV8	IACT
DIMETHICONE	92RU3N3Y1O	IACT
SILICON	Z4152N8IUI	IACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
Version	Effective date	Source	Hydrated
9	2023-10-09	full-release	2026-05-31 23:56:37

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 10 · 572 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	TABLET, COATED / ORAL	54.7 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
LAURIC DIETHANOLAMIDE	LAURIC DIETHANOLAMIDE	I29I2VHG38	SHAMPOO / TOPICAL	20 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	DROPS / ORAL	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
EDETIC ACID	EDETIC ACID	9G34HU7RV0	TABLET, FILM COATED / ORAL	0.2 mg		Exact identifier — unii candidate 13 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL / TOPICAL		4522 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET, DELAYED RELEASE / ORAL		36 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / RESPIRATORY (INHALATION)		43 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	LIQUID / NASAL	7.4 mg/1ml		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	LIQUID / SUBCUTANEOUS	0.7 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	LOTION / TOPICAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, ORALLY DISINTEGRATING / ORAL		6 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / INTRATYMPANIC		2 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	LOTION / TOPICAL		3392 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)	8136Y38GY5	TABLET, FILM COATED / ORAL	1 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SPRAY / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
SODIUM BISULFITE	SODIUM BISULFITE	TZX5469Z6I	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	51.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	CREAM / TOPICAL		76000 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		2350 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / BUCCAL	15 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / EPIDURAL		648 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	ELIXIR / ORAL	800 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	POWDER, FOR SOLUTION / OPHTHALMIC	0.9 %w/w		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM BISULFITE	SODIUM BISULFITE	TZX5469Z6I	INJECTION / SUBCUTANEOUS	0.22 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, DELAYED RELEASE PARTICLES / ORAL		56 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)	8136Y38GY5	SYRUP / ORAL	100 mg/5ml		Exact identifier — unii candidate 9 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO, SUSPENSION / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	FILM / BUCCAL		1 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, COATED / ORAL	1 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
SODIUM BISULFITE	SODIUM BISULFITE	TZX5469Z6I	INJECTION / SOFT TISSUE	0.1 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	INJECTION, SOLUTION / INTRAMUSCULAR		1000 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
SODIUM BISULFITE	SODIUM BISULFITE	TZX5469Z6I	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	51.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	AEROSOL, FOAM / VAGINAL	6.4 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	AEROSOL, SPRAY / RESPIRATORY (INHALATION)	35.75 %w/w		Exact identifier — unii candidate 59 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SHAMPOO / TOPICAL	8 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET / SUBLINGUAL	1 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SYRUP / ORAL		81 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
SODIUM BISULFITE	SODIUM BISULFITE	TZX5469Z6I	INJECTION / INTRAVENOUS		96 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	SOLUTION / RECTAL	0.01 %w/v		Exact identifier — unii candidate 15 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	DROPS / ORAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	EMULSION / TOPICAL	8 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	LOTION / TOPICAL		351 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / ORAL		346 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	INJECTION / INTRAMUSCULAR		1491 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	AEROSOL, FOAM / TOPICAL	0.16 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, COATED / ORAL		17 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	AEROSOL, FOAM / TOPICAL	0.27 %w/w		Exact identifier — unii candidate 29 equally ranked IID candidates
SODIUM BISULFITE	SODIUM BISULFITE	TZX5469Z6I	SYRUP / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SPRAY / SUBLINGUAL		397 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / OPHTHALMIC	0.6 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / AURICULAR (OTIC)	0.01 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / INTRAMUSCULAR	9 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	DROPS / OPHTHALMIC	0.08 %w/w		Exact identifier — unii candidate 134 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, COATED / ORAL	320.75 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / NASAL	250 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	AEROSOL, FOAM / RECTAL		1214 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET / ORAL		64 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, FOR SUSPENSION / ORAL		24 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	JELLY / TOPICAL	20 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, CHEWABLE / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / INTRA-ARTERIAL		278 mg	Exact identifier — unii candidate 134 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
074cf888-7213-31ad-e063-6394a90a16d8			d02ace0b-7244-45d4-987f-eb569303a426	2023-10-09	Warnings	Exact identifier spl set id: d02ace0b-7244-45d4-987f-eb569303a426

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.